Fig. 3From: TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer riskProbability distributions comparing NC ALL vs CA subjects for the CBM, the PLCOM2012 Risk Score (PRS) alone, and TP53 biomarker alone. The difference between NC ALL and CA was significant for the CBM (P = 1.436e-09), the PRS alone (P = 2.696e-06), and the TP53 biomarker alone (P = 3.856e-06)Back to article page